Anagha Suhas Kulkarni

Title: Anagha Suhas Kulkarni: Innovator in Pharmaceutical Compounds

Introduction

Anagha Suhas Kulkarni is a notable inventor based in Maharashtra, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 2 patents to her name, her work focuses on addressing critical health issues.

Latest Patents

Anagha's latest patents include innovative compounds that have potential therapeutic uses. One of her notable inventions is related to benzoxazepine compounds, which are designed for the treatment of insulin resistance and associated clinical conditions. This invention provides a novel benzoxazepine compound of the general formula (I), along with a process for its preparation and a pharmaceutical composition that includes an effective amount of the compound.

Another significant patent involves antiarrhythmic and cardioprotective substituted indenoylguanidines. This patent describes the compounds of formula I and formula II, their preparation process, and their use as medicaments. These compounds are particularly useful for treating cardiac arrhythmias and serve as cardioprotective agents in mammals.

Career Highlights

Anagha has worked with prominent companies in the pharmaceutical industry, including Hoechst Aktiengesellschaft and Piramal Healthcare Limited. Her experience in these organizations has contributed to her expertise in developing innovative medical solutions.

Collaborations

Anagha has collaborated with notable colleagues, including Bansi Lal and Nigrogi Venkata Ramakrishna. These collaborations have likely enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Anagha Suhas Kulkarni is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on healthcare. Her innovative patents reflect her commitment to addressing critical medical challenges.